XRP Healthcare, a trailblazer in healthcare innovation, has officially finalized the acquisition of Pharma Ville, a prominent retail and wholesale pharmacy network in Uganda. This pivotal move marks XRP Healthcare’s strategic entrance into Africa’s dynamic and rapidly growing healthcare landscape, positioning the company to drive scalable, tech-powered pharmaceutical distribution throughout the continent.
Strengthening Healthcare Access Across Uganda
Pharma Ville, with its network of two retail outlets and five wholesale distribution centers, brings a well-established infrastructure that will significantly boost nationwide access to essential medicines. By integrating Pharma Ville’s reach and capabilities, XRP Healthcare is set to streamline pharmaceutical supply chains and reinforce its presence within Africa’s evolving healthcare market.
Legal Support for a Smooth Transition
To ensure a seamless transaction, Shonubi Musoke & Co. Advocates, in partnership with Norton Rose Fulbright, provided comprehensive legal counsel, navigating regulatory complexities and solidifying XRP Healthcare’s position in Uganda.
Pharma Ville’s Strategic Role and Expansive Portfolio
Known for its vital role in supporting Uganda’s healthcare ecosystem, Pharma Ville collaborates closely with the National Medical Stores (NMS) and Joint Medical Stores (JMS) to ensure consistent delivery of crucial medications.
The acquisition encompasses:
- 60 registered pharmaceutical products
- 18 products primed for immediate market release
- 70 additional products pending regulatory clearance
Moreover, Pharma Ville holds strategic distribution agreements with eight global pharmaceutical giants, including:
- Toros Group (Switzerland) – Orthopedic supplies
- Ascensia Switzerland (Germany) – Diabetes care solutions
- Incepta Pharmaceuticals (Bangladesh) – Human medicines
- Amanta Health Care (India) – IV fluids
- Forans Latvia (Latvia) – Diabetic care
- Mediteks (Turkey) – Surgical tools
- Naari Pharma (India) – Human pharmaceuticals
- Universal Corporation (Kenya) – Human medicines
Leadership Perspectives on the Acquisition
Richard Kitonsa, Founder and CEO of Pharma Ville, described the deal as a game-changer:
“Becoming part of XRP Healthcare gives us the leverage to scale faster, adopt cutting-edge technologies, and meet Uganda’s healthcare needs more effectively.”
Whitney Lynn, Chairman of XRP Healthcare, emphasized the company’s mission:
“Our focus is straightforward — making vital medicines both accessible and affordable. Acquiring Pharma Ville is a significant milestone in that journey.”
Kain Roomes, CEO of XRP Healthcare, highlighted the vast opportunities in Uganda’s healthcare sector:
“The fragmented pharmaceutical market here presents huge potential. By integrating Pharma Ville, we can deliver immediate improvements in access and healthcare efficiency.”
Laban Roomes, COO of XRP Healthcare, noted the groundwork already laid for growth:
“We’ve worked diligently in Uganda to establish the necessary legal and operational frameworks for rapid expansion. These foundations will drive sustainable improvements in healthcare access.”
Planned Enhancements and Future Vision
As part of immediate post-acquisition improvements, XRP Healthcare plans to:
- Introduce advanced inventory and supply chain systems
- Expand product licensing for a broader range of medicines
- Strengthen distribution networks for deeper market penetration
- Implement digital payment solutions for seamless transactions
- Deploy CRM platforms to enhance patient and customer engagement
By Q4, Pharma Ville will officially rebrand under the XRP Healthcare name, aligning with the company’s broader vision of healthcare innovation and excellence.
Integrating AI for Smarter Healthcare
Already, Pharma Ville has integrated XRP Healthcare’s XRPH AI App, a multilingual virtual healthcare assistant that provides personalized medical support in Luganda, Swahili, Kinyarwanda, French, and English via www.pharmaville.ai.
An upcoming update will allow users to upload images of medical issues for AI-powered assessments, with direct referral pathways to healthcare professionals for urgent cases — a revolutionary step for patient care in Uganda.
Global Endorsements and Future Growth
Peter Waiswa, an advisor to UNICEF, the Bill & Melinda Gates Foundation, and now XRP Healthcare, applauded the move:
“This acquisition is a leap forward for Uganda’s healthcare system, driving both innovation and economic development.”
As Africa’s healthcare market is projected to hit $259 billion by 2030, with AI and digital health expected to account for $16.6 billion, XRP Healthcare is strategically positioned to harness these massive growth opportunities.
Looking Ahead: Global Expansion
XRP Healthcare has secured registered trademarks in Uganda, UAE, and the UK, with more global filings underway, underscoring its commitment to innovation and brand integrity.
Furthermore, XRP Healthcare has hinted at a major global announcement set to be revealed later this quarter, signaling broader strategic ambitions beyond Africa.
About XRP Healthcare
XRP Healthcare stands at the forefront of merging AI-driven solutions with strategic healthcare acquisitions to transform access and efficiency in emerging markets. By fusing digital innovation with traditional pharmaceutical distribution, XRP Healthcare is redefining how healthcare is delivered worldwide.
